 The development of a regulatory framework concerning genetic engineering began in 1975, at Asilomar, California.The Asilomar meeting recommended a set of guidelines regarding the cautious use of recombinant technology and any products resulting from that technology.The Cartagena Protocol on Biosafety was adopted on 29 January 2000 and entered into force on 11 September 2003.